Company Dynamic

Merck's revenue grew by 18% in the third quarter, with projected annual sales of Keytruda exceeding $29 billion, potentially reaching $30 billion. The 15-valent pneumonia vaccine generated $239 million in revenue, a 13% increase.

Lecta, a European manufacturer and distributor of specialty papers for labels and packaging, announces the spin-off of its self-adhesive business unit from Torraspapel SAU. The spin-off will take effect on January 1, 2025.

• Lecta

BASF has completed the International Sustainability and Carbon Certification (ISCC) PLUS certification program for the production of biomass-balanced thermoplastic polyurethanes at its production site in Lemford, Germany.

• BASF
• ISCC plus

INEOS Enterprises has reached an agreement with KPS Capital Partners to sell the INEOS Composites business to the latter for an estimated consideration of approximately €1.7 billion upon completion of the transaction.

• INEOS
• KPS Capital Partners

To strengthen its competitive advantage in Latin America, Swiss flavors, fragrances and active cosmetic ingredients manufacturer Givaudan has inaugurated a newly expanded production facility at its Pedro Escobedo site in Mexico.

• Givaudan

Sanofi announced its largest investment in China, pledging 1 billion euros to build a new insulin production facility in the Beijing Economic and Technological Development Zone.

• Sanofi

Recently, international media reported that the Tamil Nadu government in India has offered Foxconn approximately 200 acres of land to advance the construction of its planned Battery Energy Storage System (BESS) factory, with negotiations nearing completio

Recently, as a leading enterprise in the carbon fiber equipment industry, Zhejiang Jinggong Integration Technology successfully signed two major contracts totaling 1.764 billion RMB, surpassing the company’s projected annual revenue of 1.54 billion RMB fo

Recently, major Japanese chemical companies released their financial reports for the first half of the 2024-2025 fiscal year. The reports indicate that due to rising raw material costs, the profitability of these companies generally remains unsatisfactory

According to two sources familiar with the plan, Danish pharmaceutical giant Novo Nordisk is establishing a new label team in India to strengthen its global market leadership, aiming to launch its popular weight loss drug Wegovy ahead of competitors like

Sanofi announced on Monday plans to invest approximately €1 billion (equivalent to $1.05 billion) to build a new insulin production base in Beijing. This move will represent the French pharmaceutical giant's largest single investment in China to date.

According to the latest monitoring data, at least 19 pharmaceutical companies globally announced layoffs or business streamlining plans in November.

Recently, Zhejiang Anglikang Pharmaceutical Co., Ltd. has completed the filing and public announcement for a project to produce 4,105 tons of D(-)-Hydroxyphenylglycine Methyl Ester and 1,230 tons of D(-)-Phenylglycine Hydrochloride.

Zeren Group has successfully completed the acquisition of Türkiye Petrolleri (TP Petrol Dagitim AS), one of Turkey’s largest fuel retail chains, having received all necessary regulatory approvals.

• Zeren
• Türkiye Petrolleri

Unilever and global agricultural innovation company Nufarm announced a strategic partnership on November 26 to promote the technology development and future commercialization of ‘crops of the future’.

• Unilever
• Nufarm

PPG has completed the sale of 100% of its architectural coatings business in the United States and Canada to industrial investor American Industrial Partners (AIP) for $550 million.

• PPG
• architectural coatings

On December 2, 2024, Merck's combination antibiotic injection, Imipenem/Cilastatin/Relebactam (containing 500mg imipenem, 500mg cilastatin, and 250mg relebactam), received marketing approval from China's National Medical Products Administration.

Recently, AstraZeneca announced a significant personnel adjustment on its official website, appointing Bob Li, an Asian scientist from the Memorial Sloan Kettering Cancer Center (MSK) in the U.S., as the new head of global medical affairs in oncology.

In November, the pharmaceutical industry experienced significant changes in executive personnel, with adjustments at several well-known domestic and international enterprises drawing widespread attention.

Keijzer concluded by stating that each strategic task is equipped with a tailored strategy that will determine resource allocation and reshape the company's innovation process to ensure systematic implementation of these strategies.